170 related articles for article (PubMed ID: 25491923)
1. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis.
van der Leest RJ; Flohil SC; Arends LR; de Vries E; Nijsten T
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1053-62. PubMed ID: 25491923
[TBL] [Abstract][Full Text] [Related]
2. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
3. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
[TBL] [Abstract][Full Text] [Related]
4. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
5. Melanoma survivors are at increased risk for second primary keratinocyte carcinoma.
Sun H; Li Y; Zeng F; Meng Y; Du S; Deng G
Int J Dermatol; 2022 Nov; 61(11):1397-1404. PubMed ID: 35726477
[TBL] [Abstract][Full Text] [Related]
6. Occupation and keratinocyte cancer risk: a population-based case-control study.
Marehbian J; Colt JS; Baris D; Stewart P; Stukel TA; Spencer SK; Karagas MR
Cancer Causes Control; 2007 Oct; 18(8):895-908. PubMed ID: 17638107
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
8. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
11. Non melanoma skin cancer and subsequent cancer risk.
Rees JR; Zens MS; Gui J; Celaya MO; Riddle BL; Karagas MR
PLoS One; 2014; 9(6):e99674. PubMed ID: 24937304
[TBL] [Abstract][Full Text] [Related]
12. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications.
Marghoob AA; Slade J; Salopek TG; Kopf AW; Bart RS; Rigel DS
Cancer; 1995 Jan; 75(2 Suppl):707-14. PubMed ID: 7804999
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Ultraviolet Radiation Exposure and Skin Cancer Risk: the E3N-SunExp Study.
Savoye I; Olsen CM; Whiteman DC; Bijon A; Wald L; Dartois L; Clavel-Chapelon F; Boutron-Ruault MC; Kvaskoff M
J Epidemiol; 2018 Jan; 28(1):27-33. PubMed ID: 29176271
[TBL] [Abstract][Full Text] [Related]
14. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
15. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
16. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
17. National incidence of eyelid cancer in Ireland (2005-2015).
Quigley C; Deady S; Hughes E; McElnea E; Zgaga L; Chetty S
Eye (Lond); 2019 Oct; 33(10):1534-1539. PubMed ID: 30976073
[TBL] [Abstract][Full Text] [Related]
18. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
[TBL] [Abstract][Full Text] [Related]
19. Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland.
Cantwell MM; Murray LJ; Catney D; Donnelly D; Autier P; Boniol M; Fox C; Middleton RJ; Dolan OM; Gavin AT
Br J Cancer; 2009 Jan; 100(1):174-7. PubMed ID: 19127269
[TBL] [Abstract][Full Text] [Related]
20. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
